GA + MGD meet FDA

Do you struggle when training eye care professionals in your office? Need to know where to turn for help? Join this week’s hosts, Jimmy and Roya, as they share tips on training their staff and the programs and training modules available.¬†

Hear about the recent FDA approval of Syfovre, the first treatment for geographic atrophy, a leading cause of blindness worldwide. In addition, they discuss the new and different treatment options for MGD. 

Have an idea for a topic you would like to hear more about, or would you like to nominate or be a guest on Try Not 2 Blink? We want to hear from you! Click here to send in a suggestion, or email us at [email protected]

SOURCES

HOYA Training Program

Paraoptometric Certification

Syfovre is AMGDpproved

Pipeline Treatment for GA

TP-03 for Tarsus

NOV03 for DED+MGD

AZR-MD-001 for MGD

Try Not to Blink Podcast  is powered by Valley Contax

Facebook
Instagram
Twitter